Information Update - UPDATE: Mint Pharmaceuticals Inc. recalls all lots of losartan

OTTAWA, ON, Oct. 26, 2021 /CNW/ - Mint Pharmaceuticals Inc. is recalling all lots of its prescription losartan tablets, in 50 mg and 100 mg strengths, after tests found an azido impurity (5-(4'-((5-(azidomethyl)-2-butyl-4-chloro-1H imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H tetrazole) above the acceptable limit. Long-term exposure to the impurity at levels above what is considered safe could potentially increase the risk of cancer.

Please see the full advisory for more information, including what Canadians should do and Health Canada's work to address the issue of azido impurities found in certain drugs.

Product	Company	DIN	Lot	Expiry
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02389657	2005006959	April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02389657	2005006960	April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02389657	2005006961	April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02389657	2005006962	April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02389657	2005006963	April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02389657	2005011154	June 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02389657	2005011156	June 2023
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02389665	2005006807	April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02389665	2005006808	April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02389665	2005006809	April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02389665	2005006810	April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02389665	2105002149	December 2022
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	1805012687	October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	1805012688	October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	1805012689	October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	1805012792	October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	1905001010	December 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	1905001011	December 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	2005006947	April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	2005006949	April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	2005006950	April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	2005006951	April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	2005007297	April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	2005007298	April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	2005013776	August 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS	Mint Pharmaceuticals Inc.	02389673	2105002150	December 2023

Également disponible en français

SOURCE Health Canada

Media Inquiries: Health Canada, [phone], [email protected]; Public Inquiries: [phone], 1-866 225-0709, [email protected]